SCYNEXIS Reports First Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
SCYNEXIS Reports First Quarter 2024 Financial Results and Provides Corporate Update
Investors in SCYNEXIS (NASDAQ:SCYX) have unfortunately lost 87% over the last five years [Yahoo! Finance]
SCYNEXIS Presented Preclinical Data on Second Generation Fungerp SCY-247 at the Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global, Formerly ECCMID) [Yahoo! Finance]
SCYNEXIS Presented Preclinical Data on Second Generation Fungerp SCY-247 at the Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global, Formerly ECCMID)